Internationale Partnersuche

Innovation & Technologie Angebot

Transdermal delivery cream that delivers water-based active ingredients across the skin

Country of Origin: Singapore
Reference Number: TOSG20190508001
Publication Date: 9 May 2019

Summary

A Singapore-based technology SME has developed a transdermal delivery system that delivers the water-based active ingredient into the bloodstream through the skin. 

The trade-secret formulation comes in the form of an applied-on cream. Water-based active molecules are delivered across the skin in a sustained manner, facilitating delivery into the bloodstream for better absorption.

The SME seeks research cooperation manufacturing partnerships with MNEs or SMEs or all sizes.

Description

The transdermal delivery technology developed by the Singapore SME has been clinically proven effective in delivering active molecules like Glucosamine, Ribose, Creatine, Carnitine, Caffeine and Capsaicin.



The active ingredients are delivered as an applied-on cream into the bloodstream through the skin. Clinical trials have shown positive outcome and effectiveness of the technology. Several products have been commercialised with this transdermal technology. 



The Singapore-based SME has been in the market for more than 10 years in research, development, manufacturing of their transdermal and seeks to partner industry players from Europe in introducing this technology to European markets.



The SME provides toll manufacturing, OEM and lab testing services of their technology to collaborators and partners.

The Singapore SME is keen to the following types of partnerships with MNEs or SMEs of all sizes:



1) R&D agreement - The partner engages the Singapore SME as a provider to develop a product based on their technology.



2) Manufacturing agreement - The partner can engage the Singapore SME to manufacture the finished product.

Advantages and Innovations

The transdermal delivery technology provides a controlled, sustained release of the active ingredient into the bloodstream, compared to other medication delivery like oral, topical, intravenous and intramuscular delivery methods.

Stage Of Development

Already on the market

Stage Of Development Comment

The technology has already been used in the market in several products since the early 2000s. The technology provider seeks to expand the application of the technology into new markets, beyond Southeast Asia.

Requested partner

The SME seeks to partner SMEs of all sizes through the following modes of cooperation:



1) Research Cooperation agreement - The partner engages the Singapore SME as a research collaboration partner to develop a product based on the SME’s technology.



2) Manufacturing agreement - The partner can establish a contract manufacturing contract with the SME in leveraging the skills, expertise and know-how of the SME.